Diabetes increases the risk of serious adverse events after re-irradiation of the spine.
Metastatic spinal cord compression
Palliative
Radiotherapy
Spine
Toxicity
Journal
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
28
11
2018
revised:
26
03
2019
accepted:
02
04
2019
pubmed:
25
4
2019
medline:
1
4
2020
entrez:
25
4
2019
Statut:
ppublish
Résumé
In this study we investigate the risk of radiation-induced serious adverse event of the spine in a large cohort of consecutive retreated patients with palliative radiotherapy (RT) for metastatic cancer in the spine. From 2010 to 2014, 2387 patients received spinal irradiation with a palliative intent for metastatic spinal cord compression at our institution. The patients were reviewed for prior RT and 220 patients had received re-irradiation of the spine. Clinical and treatment data were obtained from the patients' records and the RT planning system. Patients had metastatic disease from breast, prostate, lung, hematological or other cancers (22.7%, 21.8%, 21.4%, 3.2% and 30.9%, respectively). Median follow-up was 99 days. Median cumulative EQD2 was 57.6 Gy The incidence of RIM and RIF (6 and 9 out of 220 patients, respectively) was low in our cohort of re-irradiated patients. Patients with diabetes had a higher risk of adverse events which should be considered before re-irradiation of the spine.
Identifiants
pubmed: 31015114
pii: S0167-8140(19)30161-6
doi: 10.1016/j.radonc.2019.04.002
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
130-135Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.